A panel of advisers recommended the Centers for Disease Control and Prevention add Pfizer Inc.’s RSV vaccine to the list of shots for pregnant people in order to protect infants from the sometimes fatal respiratory virus.

The group of medical and public health experts voted 11-1 for the shot Abrysvo to be administered to pregnant women between 32 to 36 weeks of gestation. CDC Director Mandy Cohen must now decide whether to make the recommendation official, which would allow the vaccine to be administered as soon as it’s available.

The Food and Drug Administration approved the shot in August, yet with a warning that 5.7% of participants in a vaccine study had pre-term births, versus 4.7% in the placebo group.